Overall, the results from the present study underpin a novel mechanism of TQ against CRC progression by a reduction in the glycolytic rate, possibly mediated via the PI3K-AKT/HK2 axis (Figure 6). The gene discussed is AKT1; the disease is colorectal carcinoma.